Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
J Lipid Res. 2014 Feb;55(2):313-8. doi: 10.1194/jlr.P044982. Epub 2013 Dec 8.
There is a continuous flux of the oxysterol 27-hydroxycholesterol (27-OHC) from the circulation across the blood-brain barrier (BBB) into the brain. The major metabolite of 27-OHC in the brain is 7α-hydroxy-3-oxo-4-cholestenoic acid (7-HOCA). We confirm a recent report describing the presence of this metabolite in cerebrospinal fluid (CSF) at a relatively high concentration. A simple and accurate method was developed for assay of 7-HOCA in CSF based on isotope dilution-mass spectrometry and use of (2)H4-labeled internal standard. The concentration of this metabolite was found to be markedly increased in CSF from patients with a dysfunctional BBB. There was a high correlation between the levels of 7-HOCA in CSF and the CSF/serum albumin ratio. The concentration of 7-HOCA in CSF was not significantly affected by neurodegeneration. Our findings suggest that 7-HOCA could be used as a diagnostic marker for conditions with a dysfunctional BBB.
有一种名为 27-羟胆固醇(27-OHC)的氧化固醇不断从血液中穿过血脑屏障(BBB)进入大脑。27-OHC 在大脑中的主要代谢产物是 7α-羟基-3-氧代-4-胆甾烯酸(7-HOCA)。我们证实了最近的一份报告,该报告描述了这种代谢物在脑脊液(CSF)中以相对较高的浓度存在。我们基于同位素稀释质谱法和使用(2)H4-标记的内标,开发了一种用于 CSF 中 7-HOCA 检测的简单而准确的方法。结果发现,该代谢物在 BBB 功能障碍患者的 CSF 中的浓度显著增加。CSF 中 7-HOCA 的水平与 CSF/血清白蛋白比值之间存在高度相关性。CSF 中 7-HOCA 的浓度不受神经退行性变的显著影响。我们的研究结果表明,7-HOCA 可用作 BBB 功能障碍相关疾病的诊断标志物。